Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

The new delivery method for dutasteride is more effective and has fewer side effects.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Certain natural compounds called terpenes may help prevent prostate cancer.

Early balding may be a sign of future prostate problems.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Fat tissue-derived cells show promise for repairing body tissues, but more research and regulation are needed for safe use.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.